NDC50474-0300-50 — THEOPHYLLINE EXTENDED-RELEASE CA

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC50474-0300-50: THEOPHYLLINE EXTENDED-RELEASE CA.

THEOPHYLLINE EXTENDED-RELEASE CA. Key specifications include special_features: ANHYDROUS, primary_container_type: BOTTLE, therapeutic_equivalent: TO THEO-24 CR CAPSULES BY SEARLE LABORATORIES, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, active_medicament_medicinal_strength: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 500S BT. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-275-6048, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC50474-0300-50

NSN: 6505-01-275-6048
FSC: 6505 — Drugs and Biologicals
CAGE: 66911 — RUSS PHARMACEUTICALS INC (USA)

SPECIFICATIONS

special_features	ANHYDROUS
primary_container_type	BOTTLE
therapeutic_equivalent	TO THEO-24 CR CAPSULES BY SEARLE LABORATORIES
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
active_medicament_medicinal_strength	300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT
part_name_assigned_by_controlling_agency	THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 500S BT
capsule_primary_container_content_quantity	500.000
NSN	6505-01-275-6048

COMPONENT DIAGRAM

KEY FEATURES

•

THERAPEUTIC EQUIVALENT: TO THEO-24 CR CAPSULES BY SEARLE LABORATORIES

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

PRIMARY CONTAINER TYPE: BOTTLE

•

CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 500.000

•

ACTIVE MEDICAMENT MEDICINAL STRENGTH: 300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT

TECHNICAL CHARACTERISTICS

THERAPEUTIC EQUIVALENT	TO THEO-24 CR CAPSULES BY SEARLE LABORATORIES
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPE	BOTTLE
SPECIAL FEATURES	ANHYDROUS
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY	500.000
PART NAME ASSIGNED BY CONTROLLING AGENCY	THEOPHYLLINE EXTENDED-RELEASE CAPSULES USP 300MG 500S BT
ACTIVE MEDICAMENT MEDICINAL STRENGTH	300.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT

OTHER ITEMS IN FSC 6505 — Drugs and Biologicals

Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.

6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347

SUBSTITUTES & CROSS-REFERENCES 1

NDC50111-0459-02Same NSN cross-reference

Same NSN cross-reference

Also cataloged under this NSN

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedAcquisition advice: Terminal item — stock exhausted; no further procurementNo demilitarization required

Ready to buy NDC50474-0300-50?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC50474-0300-50?

NDC50474-0300-50 is a THEOPHYLLINE EXTENDED-RELEASE CA.

What parts can replace NDC50474-0300-50?

There is 1 known substitute for NDC50474-0300-50: NDC50111-0459-02. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC50474-0300-50?

NDC50474-0300-50 is cataloged in the U.S. Government catalog under NSN 6505-01-275-6048. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC50474-0300-50 — THEOPHYLLINE EXTENDED-RELEASE CA

Request a Quote — NDC50474-0300-50